Adherence to multidomain interventions for dementia prevention: Data from the FINGER and MAPT trials

Nicola Coley, Tiia Ngandu, Jenni Lehtisalo, Hilkka Soininen, Bruno Vellas, Edo Richard, Miia Kivipelto, Sandrine Andrieu, Pim van Gool, Eric Moll van Charante, Cathrien Beishuizen, Susan Jongstra, Tessa van Middelaar, Lennard van Wanrooij, Marieke Hoevenaar-Blom, Mariagnese Barbera, Francesca Mangiasche, Juliette Guillemont, Yannick Meiller, Bram van de GroepCarol Brayne, Alina Solomon, Tiina Laatikainen, Timo Strandberg, Jaakko Tuomilehto, Riitta Antikainen, Jaana Lindström, Satu Havulinna, Rainer Rauramaa, Tuomo Hänninen, Lars Bäckman, Anna Stigsdotter-Neely, Antti Jula, Markku Peltonen, Esko Levälahti, Marko Grönholm, Katri Hemiö, Sophie Guyonnet, Isabelle Carrié, Lauréane Brigitte, Catherine Faisant, Françoise Lala, Julien Delrieu, H. lène Villars, Emeline Combrouze, Carole Badufle, Audrey Zueras, Christelle Cantet, Christophe Morin, Gabor Abellan van Kan, Charlotte Dupuy, Yves Rolland, C. line Caillaud, Pierre-Jean Ousset, Bertrand Fougère, Sherry Willis, Sylvie Belleville, Brigitte Gilbert, Francine Fontaine, Jean-François Dartigues, Isabelle Marcet, Fleur Delva, Alexandra Foubert, Sandrine Cerda, Marie-Noëlle-Cuffi, Corinne Costes, Olivier Rouaud, Patrick Manckoundia, Valérie Quipourt, Sophie Marilier, Evelyne Franon, Lawrence Bories, Marie-Laure Pader, Marie-France Basset, Bruno Lapoujade, Valérie Faure, Michael Li Yung Tong, Christine Malick-Loiseau, Evelyne Cazaban-Campistron, Françoise Desclaux, Colette Blatge, Thierry Dantoine, C. cile Laubarie-Mouret, Isabelle Saulnier, Jean-Pierre Clément, Marie-Agnès Picat, Laurence Bernard-Bourzeix, Stéphanie Willebois, Iléana Désormais, Noëlle Cardinaud, Marc Bonnefoy, Pierre Livet, Pascale Rebaudet, Claire Gédéon, Catherine Burdet, Flavien Terracol, Alain Pesce, Stéphanie Roth, Sylvie Chaillou, Sandrine Louchart, Kristelle Sudres, Nicolas Lebrun, Nadège Barro-Belaygues, Jacques Touchon, Karim Bennys, Audrey Gabelle, Aurélia Romano, Lynda Touati, C. cilia Marelli, C. cile Pays, Philippe Robert, Franck le Duff, Claire Gervais, S. bastien Gonfrier, Yannick Gasnier, Serge Bordes, Danièle Begorre, Christian Carpuat, Khaled Khales, Jean-François Lefebvre, Samira Misbah el Idrissi, Pierre Skolil, Jean-Pierre Salles, Carole Dufouil, Stéphane Lehéricy, Marie Chupin, Jean-François Mangin, Ali Bouhayia, Michèle Allard, Frédéric Ricolfi, Dominique Dubois, Marie Paule Bonceour Martel, François Cotton, Alain Bonafé, Stéphane Chanalet, Françoise Hugon, Fabrice Bonneville, Christophe Cognard, François Chollet, Pierre Payoux, Thierry Voisin, Sophie Peiffer, Anne Hitzel, Michel Zanca, Jacques Monteil, Jacques Darcourt, Laurent Molinier, H. lène Derumeaux, Nadège Costa, Christian Vincent, Bertrand Perret, Claire Vinel, Pascale Olivier-Abbal

Research output: Contribution to journalArticleAcademicpeer-review

65 Citations (Scopus)

Abstract

Introduction: Multidomain interventions, targeting multiple risk factors simultaneously, could be effective dementia prevention strategies, but may be burdensome and not universally acceptable. Methods: We studied adherence rates and predictors in the Finnish Geriatric Intervevntion Study to Prevent Cognitive Impairment and Disability and Multidomain Alzheimer Preventive Trial prevention trials, for all intervention components (separately and simultaneously). Finnish Geriatric Intervevntion Study to Prevent Cognitive Impairment and Disability participants received a 2-year multidomain lifestyle intervention (physical training, cognitive training, nutritional counseling, and cardiovascular monitoring). Multidomain Alzheimer Preventive Trial participants received a 3-year multidomain lifestyle intervention (cognitive training, physical activity counseling, and nutritional counseling) with either an omega-3 supplement or placebo. Results: Adherence decreased with increasing intervention complexity and intensity: it was highest for cardiovascular monitoring, nutritional counseling, and the omega-3 supplement, and lowest for unsupervised computer-based cognitive training. The most consistent baseline predictors of adherence were smoking and depressive symptoms. Discussion: Reducing participant burden, while ensuring that technological tools are suitable for older individuals, maintaining face-to-face contacts, and taking into account participant characteristics may increase adherence in future trials.
Original languageEnglish
Pages (from-to)729-741
JournalAlzheimer s & dementia
Volume15
Issue number6
DOIs
Publication statusPublished - Jun 2019

Cite this